Chemotherapy for breast cancer Doctors in Turkey — Page 2

Professor Ahmet Bilici leads the oncology department at Medipol Mega University Hospital, where he applies evidence-based drug protocols for complex breast cancer cases.

• Specialises in medical oncology with a focus on chemo-sensitive tumours
• Oversees treatment at a JCI-accredited university centre in Turkey
• Active researcher in clinical oncology with numerous international publications
• Member of the European Society for Medical Oncology (ESMO)
• Focuses on balancing rigorous treatment with patient quality of life

Associate Professor Nail Paksoy is a Board Certified medical oncologist who has served as a sub-investigator on high-profile international clinical trials for Roche and AstraZeneca.

• Specialises in chemotherapy for HER2-positive and BRCA-mutated breast cancers
• Holds European Society for Medical Oncology (ESMO) Board Certification
• Expert in treating metastatic cases and managing late-stage disease recurrence
• Extensively published in journals like Scientific Reports on long-term breast cancer outcomes
• Member of the Turkish Oncology Group with deep expertise in targeted drug therapies

Associate Professor Ayse Irem Yasin is a highly qualified medical oncologist who completed a targeted international observership at Italy's Maggiore della Carita Hospital Breast Cancer Unit.

• Holds a European Society for Medical Oncology (ESMO) Board Certification
• Gained specialist clinical experience at Cleveland Clinic and Harvard Medical School
• Specialises in managing complex systemic therapies for breast and gynaecological cancers
• Academically recognised as an Associate Professor for her contributions to oncology
• Practises at Medipol Acibadem District Hospital in Istanbul

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acibadem District Hospital, specialising in neoadjuvant chemotherapy and targeted therapies for breast cancer.

• Published over 50 scientific articles focusing on treatment responses and patient prognosis
• Expert in managing cancer-related malnutrition and cachexia to support patients during intensive chemotherapy
• Serves on the editorial board of BMC Cancer, a major international medical journal
• Member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the United Kingdom

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

Associate Professor Abdullah Sakin is a leading medical oncologist who formerly served as the Head of the Medical Oncology Department at Yüzüncü Yıl University.

• Specialises in internal medicine and medical oncology at Medipol Bahçelievler Hospital
• Managed clinical education as an Education Officer at Prof Dr Cemil Taşçıoğlu City Hospital
• Directs complex chemotherapy protocols for various malignancy types
• Hold memberships in professional societies focused on clinical oncology and research

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.